Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cavitation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00008138
What this trial is testing

S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
SWOG Cancer Research Network 62
Testing effectiveness (Phase 2)Study completedNCT00006033
What this trial is testing

Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Ended earlyNCT00003378
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 45
Testing effectiveness (Phase 2)UnknownNCT03737968
What this trial is testing

Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.

Who this might be right for
Stage II-IVB Operable HNSCC Oral CavityHypopharynxOropharynx+1 more
Yonsei University 48
Early research (Phase 1)Looking for participantsNCT07690618
What this trial is testing

Thermotherapy for Head and Neck Cancer Patients

Who this might be right for
Head and Neck CancerOropharyngeal CarcinomaHypopharyngeal Carcinoma+4 more
Erasmus Medical Center 30
Testing effectiveness (Phase 2)Ended earlyNCT05538624
What this trial is testing

Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

Who this might be right for
Neoplasm, OvarianFallopian Tube CancerPrimary Peritoneal Cavity Cancer+5 more
Avenge Bio, Inc 14
Not applicableWithdrawnNCT00951470
What this trial is testing

Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema

Who this might be right for
LymphedemaOropharyngeal CancerHead and Neck Cancer+1 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT07281066
What this trial is testing

LLM Performance in Endodontic Diagnostics

Who this might be right for
Endodontic Diagnosis, Endodontic Diseases, Endodontic Treatment, Endodontic Decision-making
Marmara University 120
Not applicableStudy completedNCT05155683
What this trial is testing

Combination of Light and Ultrasound to Reduce Abdominal Fat

Who this might be right for
Subcutaneous Fat Disorder
University of Nove de Julho 79
Not applicableStudy completedNCT03740620
What this trial is testing

The Effect of Bevel Direction on the Pathway of the Nasotracheal Tube

Who this might be right for
EpistaxisIntubation Complication
Seoul National University Hospital 68
Not applicableUnknownNCT03917524
What this trial is testing

Feasibility of CTCs Isolation for Transcriptomes and Genome Wide Associated Analysis in Post-OP High Risk OSCC Patients.

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Chang Gung Memorial Hospital 180
Not applicableEnded earlyNCT01254734
What this trial is testing

Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Lymphoepithelioma of the NasopharynxRecurrent Lymphoepithelioma of the Oropharynx+52 more
City of Hope Medical Center 7
Not applicableStudy completedNCT04755452
What this trial is testing

The Effect of Pneumoperitoneum (Raised Pressure in the Peritoneal Cavity) During Robotic Kidney/Prostate Cancer Surgery.

Who this might be right for
Acute Kidney InjuryPneumoperitoneumKidney
Aalborg University Hospital 100
Not applicableEnded earlyNCT03189316
What this trial is testing

Anti-inflammatory Cells in Peritoneal Cavity

Who this might be right for
Ovarian CystsChronic Renal Insufficiency
University Hospital, Montpellier 10
Large-scale testing (Phase 3)Ended earlyNCT02236936
What this trial is testing

Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Hypopharynx Stage IIISquamous Cell Carcinoma of the Hypopharynx Stage IVLaryngeal Squamous Cell Carcinoma Stage III+6 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 8
Testing effectiveness (Phase 2)Study completedNCT00023699
What this trial is testing

Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00702299
What this trial is testing

Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
University of Arizona 15
Testing effectiveness (Phase 2)Study completedNCT00003193
What this trial is testing

Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral Complications
Massachusetts General Hospital 37
Early research (Phase 1)Ended earlyNCT00410865
What this trial is testing

Wild Type p53 Adenovirus for Oral Premalignancies

Who this might be right for
Mouth Cancer
M.D. Anderson Cancer Center 4
Next Page